Your browser doesn't support javascript.
loading
Simple criteria to predict margin involvement after chemoradiotherapy and sphincter-sparing for low rectal cancer.
Dumont, F; Tilly, C; Dartigues, P; Goéré, D; Honoré, C; Elias, D.
Afiliación
  • Dumont F; Department of Digestive Oncological Surgery, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: Frederic.DUMONT@gustaveroussy.fr.
  • Tilly C; Department of Digestive Oncological Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
  • Dartigues P; Department of Histopathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Goéré D; Department of Digestive Oncological Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
  • Honoré C; Department of Digestive Oncological Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
  • Elias D; Department of Digestive Oncological Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
Eur J Surg Oncol ; 41(9): 1210-6, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26108736
BACKGROUND: Low rectal cancers carry a high risk of circumferential margin involvement (CRM+). The anatomy of the lower part of the rectum and a long course of chemoradiotherapy (CRT) limit the accuracy of imaging to predict the CRM+. Additional criteria are required. METHODS: Eighty six patients undergoing rectal resection with a sphincter-sparing procedure after CRT for low rectal cancer between 2000 and 2013 were retrospectively reviewed. Risk factors of CRM+ and the cut-off number of risk factors required to accurately predict the CRM+ were analyzed. RESULTS: The CRM+ rate was 9.3% and in the multivariate analysis, the significant risk factors were a tumor size exceeding 3 cm, poor response to CRT and a fixed tumor. The best cut-off to predict CRM+ was the presence of 2 risk factors. Patients with 0-1 and 2-3 risk factors had a CRM+ respectively in 1.3% and 50% of cases and a 3-year recurrence rate of 7% and 35% after a median follow-up of 50 months. CONCLUSIONS: Poor response, a residual tumor greater than 3 cm and a fixed tumor are predictive of CRM+. Sphincter sparing is an oncological safety procedure for patients with 0-1 criteria but not for patients with 2-3 criteria.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Canal Anal / Neoplasias del Recto / Recto / Adenocarcinoma / Quimioradioterapia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Canal Anal / Neoplasias del Recto / Recto / Adenocarcinoma / Quimioradioterapia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido